focus -WSS

focus

author：explore 2025-09-07 11:12:19 - browse：116

Has AI really solved biology? What can machines teach us about medicine? And what’s a digital twin?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our all-AI episode. First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials. Then, we talk to Joel Dudley, a partner at the venture firm Innovation Endeavors, about how to discern promising ideas from wastes of time when it comes to AI in biotech.

For more on what we cover, here’s the latest on AI in drug development; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Reporting on presidential health from Reagan to Trump and Biden

WSS

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Study suggests new cause of Down syndrome: cells linked to aging

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Does Paxlovid work in people vaccinated against Covid

leisure time

focus

knowledge

Affirmative action in medical school literally saved lives

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Heart attack and stroke risk calculators need revising

Flagship Pioneering startup Sonata Therapeutics lays off 21

Medical leaders decry Supreme Court decision on affirmative action

Allen Institute goes after foundational questions, CEO Costa says

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Malaria cases in Florida and Texas: Here’s what you need to know

Ukraine seeks to reclaim its role as a hub for clinical trials

hotspot

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Medicare Advantage enrollment grows 7.1% to 33.4 million people

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Abridge raises $150m as clinical notes automation market heats up

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Boston Scientific acquires urology company Axonics for $3.7 billion

Wikipedia

Wikipedia

hotspot

focus